Mammalian genomes encode thousands of noncoding RNAs. Two classes of noncoding RNAs, lncRNA and miRNAs, have important roles in regulating gene expression. lncRNAs are defined as transcripts of >200 nt that lack a canonical open reading frame and do not function by encoding proteins. lncRNAs are synthesized by RNA polymerase II, spliced and sometimes polyadenylated 1 . Many lncRNAs can regulate chromatin states by interacting with chromatinmodification complexes, which control diverse developmental processes and human diseases, including cancer 2 .
a r t i c l e s
Dcr-KO mESCs, as previously reported 9 ( Supplementary Fig. 1a,b) . We calculated a cumulative density function (cdf) plot comparing expression differences for the set of miR-295 targets as determined by seed complementarity (7-mer M8 or T1A). Relative to a control set of genes matched for 3′-UTR length, dinucleotide composition and expression level, the miR-295-target set was more derepressed upon Dcr loss ( Supplementary Fig. 1f,g ). This result shows that our sequencing data were able to faithfully show a transcriptome-wide miR-295 signature associated with mESCs.
We next compared lncRNA expression levels in WT versus Dcr-KO mESCs. Similarly to mRNAs, lncRNAs with a complementary seed match to miR-295 were also derepressed upon Dcr loss (Supplementary Fig. 1h ). However, to our surprise, the expression of hundreds of lncRNAs decreased in Dcr-KO mESCs (P = 3.95 × 10 −13 ; Fig. 1b,c) , in contrast to the expression of mRNAs, whose log 2 fold change between Dcr KO and WT was around 0. We also observed this trend when comparing mRNAs with expression level matched to that of lncRNAs in WT mESCs (Supplementary Fig. 1e ). Of 2,229 lncRNAs, 714 were significantly changed in level in Dcr KO (false discovery rate (FDR) ≤ 0.05), of which 64% were downregulated (Fig. 1d) . Over 50% (375 out of 714) of significantly regulated lncRNAs showed at least a two-fold downregulation, and over 15% of lncRNAs (113 out of 714) showed at least a four-fold downregulation. Quantitative PCR with reverse transcription (RT-qPCR) of nine lncRNAs ( Fig. 1e) and NanoString analysis of 102 lncRNAs (Fig. 2b) validated the decrease of lncRNA levels in Dcr-KO mESCs (r = 0.99 and 0.76 respectively; Supplementary Fig. 2a) . Interestingly, many of the downregulated lncRNAs are required to maintain the pluripotency and differentiation potential of mESCs 10 , thus suggesting that reduction of lncRNA levels may have important consequences in the biology of mESCs.
Canonical miRNA pathway is required for lncRNA expression
We next examined whether the canonical Dgcr8-Dcr-miRNA pathway was required for lncRNA expression in mESCs (Fig. 2a) . First, to test whether downregulated lncRNAs could be rescued by Dcr, we transfected Dcr or a catalytically dead Dcr point mutant into Dcr-KO mESCs and assayed the expression of lncRNAs by RT-qPCR and NanoString analysis. Dcr successfully rescued the expression of nearly all of the downregulated lncRNAs examined (and, as a positive control, Dcr overexpression also rescued the expression of miR-295), whereas the Dcr mutant did not, thus suggesting that the Dcr RNase III domain essential for miRNA maturation is a r t i c l e s important for lncRNA expression ( Fig. 2b and Supplementary Fig. 2b,d ). Canonical miRNA biogenesis requires processing of primary miRNAs by DGCR8 to generate substrate hairpin RNAs for DCR (Fig. 2a) . Consistently with this model, Dgcr8-KO mESCs also showed significant downregulation of lncRNAs (r = 0.72; Fig. 2b and Supplementary Fig. 2c,f,g ). Because miR-295 is the major miRNA in mESCs, we hypothesized that loss of miR-295 led to loss of lncRNAs. Indeed, overexpression of miR-295 in Dcr-KO mESCs, but not miR-96 (the second most abundant miRNA in mESCs 16 ) or a control miRNA that is not expressed in mESCs, rescued the expression of lncRNAs ( Fig. 2b and Supplementary Fig. 2b,e) . In addition, miR-295 rescued the expression of downregulated lncRNAs in Dgcr8-KO mESCs ( Supplementary Fig. 2c,e) . Taken together, these data suggest that a stepwise Dgcr8-Dcr-miR295 pathway is responsible for the expression of many lncRNAs in mESCs.
Dicer-miRNA pathway controls lncRNA transcription
To better understand the mechanism of lncRNA downregulation in Dcr-KO mESCs, we performed metabolic-labeling experiments to determine whether the decrease in lncRNA expression was due to decreased transcription or increased degradation. We treated WT and Dcr-KO mESCs with 4-thio-uridine (4sU) for 15 min (assuming negligible degradation among newly synthesized RNAs within this time frame) and assayed the expression of newly synthesized and total RNAs to calculate the rate of transcription and degradation for each lncRNA 17 ( Fig. 3a) . We performed the same calculation on several coding mRNAs and on positive controls and used published data 18 to check that our method could accurately measure their half-lives (r = 0.83, Supplementary Fig. 3a ). Although the half-lives of lncRNAs and mRNAs did not change significantly (and some even increased) in Dcr-KO mESCs, the transcription rates of downregulated lncRNAs were significantly lower in Dcr-KO mESCs (Fig. 3b,c) . In contrast, mRNAs with constant expression between WT and Dcr-KO mESCs showed constant rates of transcription ( Supplementary Fig. 3b ,c), thus suggesting that Dcr loss specifically decreased the transcription of tested lncRNAs. Chromatin-state analysis further supported the role of Dcr-miRNA pathway in lncRNA synthesis. We performed chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) of trimethylated histone H3 K4 (H3K4me3), which is associated with transcriptional initiation, and trimethylated H3 K36 (H3K36me3), which is associated with transcriptional elongation in both WT and Dcr-KO mESCs. Both modifications have been used to identify and characterize transcription of lncRNA genes 11 . Although the levels of H3K4me3 and H3K36me3 were not significantly different for lncRNAs whose expression remained constant, Dcr KO led to significant decreases in both H3K4me3 and H3K36me3 levels at downregulated lncRNA loci (P = 0.025 and 2.2 × 10 −16 respectively, Fig. 3d-g and Supplementary  Figs . 1d and 3d,e). This result suggests that both transcriptional initiation and consequent elongation of lncRNA genes are inhibited in Dcr-KO mESCs, with elongation apparently being more severely affected.
cMyc links Dcr pathway to transcription of lncRNA genes
Because lncRNA downregulation in Dcr KO seems to occur at the level of transcription, we hypothesized that these lncRNAs might be regulated by a common transcription factor which itself was downregulated upon Dcr loss. To test this hypothesis, we performed a bioinformatic screen for DNA-binding proteins whose binding sites are enriched near downregulated lncRNA loci relative to control (upregulated lncRNA) loci ( Fig. 4a and Online Methods). In addition, we focused on DNA-binding proteins whose expression was downregulated in Dcr-KO mESCs. Notably, cMyc is the only factor that met both criteria. cMyc ChIP-seq data in mESCs showed that downregulated lncRNA genes have almost four times as many cMyc-binding sites as those of upregulated lncRNA genes (Fig. 4b and Fig. 4b ). Furthermore, cMyc expression decreased by ten-fold upon Dcr loss ( Fig. 4a and Supplementary Figs. 1b  and 4a ), an effect due to the loss of miR-295 expression, as documented in previous studies 19 . RNA-seq of cMyc −/− mESCs 19 showed a downregulation of lncRNAs over mRNAs similar to that in Dcr KO (Fig. 4c) . Conversely, enforced expression of cMyc in Dcr-KO cells rescued the expression of most lncRNAs examined (Fig. 4d) . The identification of an enriched transcription factor further suggests that Dcr regulation of lncRNAs occurs indirectly through transcription.
To further ascertain the role of cMyc in regulating lncRNA expression, we compared the expression changes of lncRNA genes with and without cMyc-binding sites. Indeed, lncRNA genes with cMyc-binding sites showed greater decreases in expression compared to those without cMyc-binding sites in cMyc −/− and Dcr-KO mESCs ( Fig. 4c  and Supplementary Fig. 4c) . Intriguingly, about 40% of the protein-coding genes also had cMyc-binding sites, but they were downregulated by only 4% in Dcr-KO mESCs (Supplementary Fig. 4d ), thus suggesting that lncRNA genes are much more sensitive than protein-coding genes to cMyc expression.
To check whether cMyc affects transcription initiation and elongation of lncRNAs, we compared H3K4me3 and H3K36me3 levels at lncRNA genes with cMyc-binding sites in WT and Dcr-KO cells. Indeed, 99% of the H3K4me3 loss and 95% of the H3K36me3 loss at lncRNA gene loci in Dcr-KO cells occurred at cMyc-target genes but not at non-cMyc targets (Fig. 4e) . In contrast to lncRNA genes, levels of only H3K36me3, but not H3K4me3, at proteincoding genes with cMyc-binding sites were affected in Dcr-KO mESCs ( Supplementary Fig. 4e,f) . In addition, Pol2 ChIP-seq data with and without cMyc inhibition also showed that cMyc inhibition reduced Pol2 elongation at lncRNA genes with cMyc-binding sites (Supplementary Fig. 4g ). These results reinforce the idea that cMyc is a major determinant of transcription of lncRNA genes that affects both the transcriptional initiation and elongation.
Genomic organization affects lncRNA sensitivity to Dcr loss
To understand how transcription of lncRNA genes could be different from that of protein-coding genes, we compared the genomic contexts of both classes of transcripts (Supplementary Fig. 5a,b) . lncRNA genes were preferentially located adjacent to protein-coding genes (33% lncRNAs relative to 13% mRNAs), and these lncRNA genes were downregulated in Dcr-KO mESCs by 30% more than intergenic lncRNA genes that were not near a protein-coding gene (P < 2.2 × 10 −16 ). Interestingly, although the lncRNAs in the divergent pairs of lncRNA and protein-coding genes were downregulated in Dcr-KO mESCs, their protein-coding-gene counterparts were upregulated (although to a smaller extent), thus suggesting that lncRNA genes and proteincoding genes compete for transcription when they are divergent from each other (Supplementary Fig. 5c) .
Because cMyc has an important role in regulating synthesis of both lncRNAs and mRNAs, we wondered whether cMyc-regulated lncRNA genes overlapped with lncRNA genes that were divergent from protein-coding genes. 123 of the downregulated lncRNA genes are both cMyc targets and divergent from an adjacent protein-coding gene (Supplementary Fig. 5d ). This 46% overlap is highly significant a r t i c l e s (P = 4.4 × 10 −43 , hypergeometric distribution), thus suggesting that cMyc regulation and the genomic organization of genes encoding downregulated lncRNAs may functionally intersect. Moreover, the effect of having both features in a lncRNA gene is not additive, further supporting the idea that the two pathways are not independent from each other (Supplementary Fig. 5e ). Thus, cMyc regulation of transcription of lncRNA genes occurs most potently in the specific genomic context of divergent transcription.
Dcr and cMyc regulation of lncRNA expression is widespread
We wondered whether the effect of Dcr and cMyc on the regulation of lncRNA expression applied to additional cell types beyond mESCs. We surveyed microarray data in Gene Expression Omnibus (GEO) and Cancer Cell Line Encyclopedia (CCLE) 20 for differential regulation of lncRNAs and mRNAs (Fig. 5a) . For the effect of Dcr, we selected microarray experiments from GEO that studied Dcr KO in mouse tissues or knockdown in human cells. To study the effect of cMyc, we selected experiments from CCLE that resulted in gain or loss of cMyc expression. We mapped probes to annotated lncRNAs and mRNAs and calculated the differential expression of lncRNAs and mRNAs between perturbations versus controls (Fig. 5a) . We defined the outcomes as positive or negative decoupling, depending on the relative magnitude of expression changes between all lncRNAs and mRNAs in each experiment. Positive decoupling indicates that lncRNA expression change is significantly higher than mRNA expression change, whereas negative decoupling means relative depletion of lncRNAs (P < 0.05, FDR < 0.05; Online Methods). Indeed, Dcr loss preferentially depleted lncRNAs expressed in multiple mouse tissues in vivo and in human cells (12 significant experiments out of 19, P < 0.05; Fig. 5b) . Dcr KO led to negative decoupling of lncRNAs in adrenal-gland cells, granulocytes, liver cells, fibroblasts, inner-ear cells, T regulatory cells and HeLa cells (Fig. 5b) . Dcr KO in neurons and oocytes showed inconsistent results, and we detected positive decoupling in a single preadipocyte experiment, which may reflect experimental noise or unique regulation in this cell type. In addition, over 400 microarray experiments surveyed in CCLE had perturbed cMyc levels. These experiments covered over 35 different cell types, and not all cMyc perturbation is associated with changes in Dcr expression. We found that significant positive decoupling (lncRNA induction over mRNAs) is associated with cMyc overexpression (185/295 experiments, 66%), and significant negative decoupling is linked to cMyc depletion (100/134 experiments, 75%), consistently with our observation in mESCs (Fig. 5b) . This result suggests that regulation of lncRNAs by Dcr and cMyc is conserved between mice and humans and is widespread in diverse types of tissues in vivo and in cancer cells.
DISCUSSION
Here we provided the first demonstration, to our knowledge, that DGCR8-Dcr-miRNA circuitry can influence the expression of hundreds of lncRNAs in mESCs through transcriptional regulation (Fig. 5c) . Initially suggested by a bioinformatics screen, and later validated by gain-of-function and loss-of-function studies, the link between miRNA circuitry and lncRNA transcription acts in part through a transcriptional factor, cMyc (Fig. 5c) . In addition, cMyc seems to have the strongest effect on lncRNAs that are divergently transcribed from protein-coding genes. The quantitative difference between transcription for lncRNA and mRNA occurs in many different cell and tissue types in mice and humans, thus suggesting that the phenomenon is both widespread and important.
Tissue-specific and cell type-specific expression of lncRNAs have been highlighted by many studies 21, 22 . Our results introduce the idea that hundreds of lncRNAs can also be regulated by the same factors. Dcr emerges as a central biogenesis factor for both small and long regulatory RNAs in ES cells-via post-transcriptional RNA processing for small RNAs and as an indirect regulator of transcriptional activation of lncRNAs. Dcr requirement has been used to implicate small regulatory RNAs in diverse biological processes, and our results expand this interpretation to potentially implicate lncRNAs. npg cMyc, a master regulator of proliferation and pluripotency of mESCs 23 , affects transcriptional-pause release of thousands of protein-coding genes 24 . Our study shows that cMyc also affects expression of hundreds of lncRNA genes. In addition, lncRNA genes, especially the ones that are divergently transcribed from neighboring protein-coding genes, seem more sensitive to cMyc regulation than their protein-coding gene counterparts are. Although the exact mechanism that renders divergent lncRNA genes more sensitive to cMyc regulation is still unclear, unique features and functions of lncRNA genes may offer some explanations. For example, divergent lncRNA genes and protein-coding genes may compete for cMyc occupancy when there is limited cMyc expression. Protein-coding genes, many of which are critical in maintaining normal cellular programs, may be able to outcompete lncRNA genes for cMyc binding at their promoters. Second, divergent lncRNA genes tend to have fewer U1-binding sites and more polyadenylation sites than their protein-coding gene counterparts 25 . cMyc may be able to interact with U1 and other elongation factors that allow preferential elongation of protein-coding genes over lncRNA genes.
Although we found that cMyc and divergent genomic organization can explain a majority (over 60%) of Dcr-dependent lncRNAs in mESCs, additional mechanisms that connect Dcr to transcription may have roles (Fig. 5c) . This is partly supported by results of our Dcr-KO microarray screen, in which lncRNA downregulation was observed in many Dcr-deficient systems that do not involve cMyc (Fig. 5b) . In these systems, miRNAs other than miR-295 may be involved in regulating expression of other transcription factors or elongation factors.
Our microarray screen also shows that cMyc activity is perturbed in over 400 microarray experiments with varying degrees of Dcr expression. This suggests that cMyc itself may be able to regulate lncRNA expression independently of Dcr. cMyc has potent oncogenic activity in a broad spectrum of human cancers. Its regulation on lncRNA expression broadens the potential regulatory roles of lncRNAs in many types of cancer.
METHODS
Methods and any associated references are available in the online version of the paper. 
